Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 4
2005 7
2006 8
2007 6
2008 9
2009 2
2010 1
2011 1
2012 4
2013 1
2014 2
2015 1
2019 1
2020 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Facing facts: neuronal mechanisms of face perception.
Dekowska M, Kuniecki M, Jaśkowski P. Dekowska M, et al. Among authors: jaskowski p. Acta Neurobiol Exp (Wars). 2008;68(2):229-52. doi: 10.55782/ane-2008-1692. Acta Neurobiol Exp (Wars). 2008. PMID: 18511959 Free article. Review.
Posterior parietal cortex and developmental dyslexia.
Jaśkowski P, Rusiak P. Jaśkowski P, et al. Acta Neurobiol Exp (Wars). 2005;65(1):79-94. doi: 10.55782/ane-2005-1542. Acta Neurobiol Exp (Wars). 2005. PMID: 15794034 Free article. Review.
Conscious contributions to subliminal priming.
Jaśkowski P. Jaśkowski P. Conscious Cogn. 2008 Mar;17(1):72-83. doi: 10.1016/j.concog.2006.10.003. Epub 2006 Nov 28. Conscious Cogn. 2008. PMID: 17126565 Clinical Trial.
On the role of mask structure in subliminal priming.
Jaśkowski P, Przekoracka-Krawczyk A. Jaśkowski P, et al. Acta Neurobiol Exp (Wars). 2005;65(4):409-17. doi: 10.55782/ane-2005-1569. Acta Neurobiol Exp (Wars). 2005. PMID: 16366393 Free article. Clinical Trial.
Temporal order judgment in dyslexia.
Jaśkowski P, Rusiak P. Jaśkowski P, et al. Psychol Res. 2008 Jan;72(1):65-73. doi: 10.1007/s00426-006-0093-z. Epub 2006 Oct 7. Psychol Res. 2008. PMID: 17028891
Interplay of nitric oxide metabolites and markers of endothelial injury, inflammation, and vascular disease in the spectrum of advanced chronic kidney disease.
Batko K, Krzanowski M, Pietrzycka A, Gajda M, Dumnicka P, Fedak D, Gołasa P, Woziwodzka K, Jaśkowski P, Sułowicz W, Kuźniewski M, Litwin JA, Krzanowska K. Batko K, et al. Among authors: jaskowski p. Kardiol Pol. 2020 Jan 24;78(1):51-58. doi: 10.33963/KP.15065. Epub 2019 Nov 20. Kardiol Pol. 2020. PMID: 31746314 Free article.
45 results